West Yorkshire Continuous Glucose Monitoring (CGM) Implementation Plan Position Statement August 2024
The West Yorkshire Continuous Glucose Monitoring (CGM) Implementation Plan Position Statement provides a strategic update on our 5-year roll out plan for CGM (and hybrid closed loop (HCL)). It aims to address concerns and refocus on the cost-effectiveness of this healthcare intervention, while ensuing a structured and controlled continuation of the technology rollout empowering people with diabetes and improving health outcomes.
Continuous glucose monitoring (CGM) and Hybrid closed loop
Continuous glucose monitoring (CGM) is be available on the NHS to anyone with type 1 diabetes in West Yorkshire. Some people with type 2 diabetes may also be offered a CGM to help manage diabetes.
Children and young people will usually be offered CGM.
You can view and download all continuous glucose monitoring-related information through the following link: Medicines information :: West Yorkshire Health & Care Partnership (wypartnership.co.uk)
Decision support tool: making a decision about managing type 1 diabetes
The new decision support tool has been designed to support people to understand what is available in the NHS, providing a resource to support discussions between someone living with type 1 diabetes and their healthcare professional about appropriate steps in their care, which they are eligible for and come to a shared decision about the person’s care in managing type 1 diabetes. Download the tool and share with your patient(s).
Communication about the Wakefield CGM implementation strategy Dec 2023
This communication about the Wakefield CGM implementation strategy is specific to Wakefield only. It is designed to align the implementation of NICE guidance for both type 1 and type 2 diabetes in Wakefield Place with the WYCGM commission policy and implementation strategy. A copy of the December 2023 Wakefield CGM implementation strategy is also available as a separate document.
FAQs on diabetes med-technology
The WYICB Diabetes Med-tech Oversight Group has produced the first iteration of FAQs on Diabetes med-technology for our WY Diabetes Workforce & Clinicians. The document will be reviewed and updated quarterly as required.
NHSE FAQs HCL: Implementing the 5 Year Strategy Feb 2024
NHSE NDA HCL Specialist Services Letter April 2024
Draft West Yorkshire Continuous Glucose Monitoring (CGM) Pathway for Primary Care: For consultation until 12 July 2024
This is a DRAFT West Yorkshire CGM Pathway for primary care - drawn up to support the implementation of CGM for those eligible with type 2 diabetes (and those with type 1 diabetes choosing to have their diabetes care and support provided through primary care rather than specialist diabetes teams in secondary care).
The pathway is a first iteration and comments are sought via email to wyicb-wak.ltcpc.wy@nhs.net by 12 July 2024.
Training
Webinars
West Yorkshire Diabetes Med-tech Data Blue Print: A Solution Focused Workshop